/// Resources ///
News, Tools & Analysis
American biosecurity is contested on two fronts, and the debate moves fast. This is where ABI keeps the case in the open. Run the simulation. See who is on the record. Read what others are publishing. Follow the analysis.
/// Featured ///
The Report
Report · Jul 2026 · PDF
Regaining American Biotechnology Strength
The state of U.S. biosecurity, synthesized from federal commissions, think tanks, and universities. The finding: American capacity is contested from abroad and thinning at home, and the answer runs through targeted resilience, trusted allies, advanced manufacturing, and a stronger domestic foundation. An annotated literature map points readers to the best source on every topic.
Prepared for ABI by Start Grow Remain and Marathon Bio.
/// On the Record ///
On the Record
The public case for American biosecurity, in the words of the people making it. Op-eds, remarks, statements, testimony, and video.
The Wrong Way To Compete With China in Biotech
"Making China weaker is not the same as making America stronger."
Read ›
The China Biotech Debate
ABI served as executive sponsor of the Endpoints News China Biotech Debate, where Executive Director Jennifer Crook delivered the opening remarks. Video of her remarks is coming.
/// Intelligence ///
Latest Analysis
Sample · Live Posts Replace These
Why Medicine Is National Security
The case for treating the discovery and manufacture of American medicine as critical infrastructure.
Read ›
The Two-Front Threat
Pressure from adversary states abroad, policy failure at home, and why both have to be named at once.
Read ›
Diversify to Allies, Not Walls
Why durable supply security runs through trusted networks instead of protectionism.
Read ›
/// Reports and Coverage ///
Reports & Coverage
Research prepared for ABI, and the reporting and analysis that sharpen the case.
Regaining American Biotechnology Strength
The state of U.S. biosecurity. Prepared for ABI by Start Grow Remain and Marathon Bio, with an annotated literature map.
Why America's Medicine Became a National Security Question
ABI's case in Endpoints News: the capacity to discover, develop, and make medicine is critical national security infrastructure, and the answer is building strength, not walls.
/// Interactive ///
The Policy Simulation
Keep America Competitive and Secure
Eight policy moves, each with a case and a cost. Some compound into strength. Some collapse into shortage. Weigh the choices and see where they leave the country.